Advair diskus 100/50 and Macular opacity - a phase IV clinical study of FDA data
Macular opacity is reported only by a few people who take Advair Diskus 100/50.
The phase IV clinical study analyzes which people take Advair diskus 100/50 and have Macular opacity. It is created by eHealthMe based on reports of 38,800 people who have side effects while taking Advair diskus 100/50 from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
38,800 people reported to have side effects when taking Advair diskus 100/50.
Among them, 1 person (0.0%) has Macular opacity.
What is Advair diskus 100/50?
Advair diskus 100/50 has active ingredients of fluticasone propionate; salmeterol xinafoate. It is often used in asthma. eHealthMe is studying from 39,244 Advair diskus 100/50 users for its effectiveness, alternative drugs and more.
What is Macular opacity?
Macular opacity (opaque macula) is found to be associated with 50 drugs and 30 conditions by eHealthMe.
Number of Advair diskus 100/50 and Macular opacity reports submitted per year:
Gender of people who have Macular opacity when taking Advair diskus 100/50 *:
- female: 0.0 %
- male: 100 %
Age of people who have Macular opacity when taking Advair diskus 100/50 *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Common drugs people take besides Advair diskus 100/50 *:
- Zocor: 1 person, 100.00%
- Singulair: 1 person, 100.00%
- Requip: 1 person, 100.00%
- Paxil Cr: 1 person, 100.00%
Common side effects people have besides Macular opacity *:
- Vision Blurred: 1 person, 100.00%
- Retinal Tear: 1 person, 100.00%
Common conditions people have *:
- Restless Leg Syndrome (a powerful urge to move your legs): 1 person, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take Advair diskus 100/50 and have Macular opacity?Check whether Macular opacity is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Macular opacity and when was it recovered:
Expand to all the drugs that have ingredients of fluticasone propionate; salmeterol xinafoate:
Alternative drugs to, pros and cons of Advair diskus 100/50:
- Advair diskus 100/50 (39,244 reports)
Common Advair diskus 100/50 side effects:
- Breathing difficulty: 5,677 reports
- Drug ineffective: 4,316 reports
- Asthma: 2,999 reports
- Pneumonia: 2,393 reports
- Chest pain: 2,383 reports
- Cough: 2,369 reports
- Pain: 2,103 reports
Browse all side effects of Advair diskus 100/50:a b c d e f g h i j k l m n o p q r s t u v w x y z
Macular opacity treatments and more:
- Macular opacity (28 reports)
COVID vaccines that are related to Macular opacity:
- Macular opacity in Moderna COVID Vaccine
- Macular opacity in Pfizer BioNTech Covid Vaccine
- Macular opacity in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Macular opacity:
- Macular opacity (50 drugs)
All the conditions that are associated with Macular opacity:
- Macular opacity (30 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on fluticasone propionate; salmeterol xinafoate (the active ingredients of Advair diskus 100/50) and Advair diskus 100/50 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Emla and Myositis - now
- Primidone and Miralax drug interaction - 5 seconds ago
- Temovate and Mucous Stools - 13 seconds ago
- Urinary Incontinence in Temazepam, how severe and when it was recovered? - 15 seconds ago
- Hydroxyzine Pamoate and Entocort Ec drug interaction - 15 seconds ago
- Cannabis and Skin - Clammy - 16 seconds ago
- Duricef and Folic Acid drug interaction - 20 seconds ago
- Tramadol and D.H.E. 45 drug interaction - 22 seconds ago
- Pravachol and Finger Deformity - 22 seconds ago
- Amoxil and Apixaban drug interaction - 23 seconds ago